Literature DB >> 20210515

Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage.

Eric M Matheson1, Arch G Mainous, William J Hueston, Vanessa A Diaz, Charles J Everett.   

Abstract

Studies have found that vitamin D plays an important role in mediating immune function via a number of pathways, including enhancing the release of antimicrobial peptides in the skin. Given these findings, we hypothesize that low serum vitamin D levels may increase the risk of nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA). A secondary data analysis of the National Health and Nutrition Examination Survey 2001-2004 was performed to investigate the association between serum vitamin D levels and MRSA nasal carriage for the non-institutionalized population of the USA. An estimated 2.7 million persons (1.2% of the population) are MRSA nasal carriers. An estimated 63.3 million persons (28.4% of the population) are vitamin D deficient (serum vitamin D <20 ng/ml). In an adjusted logistic regression analysis controlling for age, race, gender, poverty income ratio, current health status, hospitalization in the past 12 months, and antibiotic use in the past month, individuals with vitamin D deficiency had a statistically significant increased risk of MRSA carriage of 2.04 (95% CI 1.09-3.84). Vitamin D deficiency is associated with an increased risk of MRSA nasal carriage. Further trials may be warranted to determine whether vitamin D supplementation decreases the risk of MRSA colonization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20210515     DOI: 10.3109/00365541003602049

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  21 in total

Review 1.  Current insights into the role of human β-defensins in atopic dermatitis.

Authors:  P Chieosilapatham; H Ogawa; F Niyonsaba
Journal:  Clin Exp Immunol       Date:  2017-08-04       Impact factor: 4.330

2.  Association between vitamin D deficiency and methicillin-resistant Staphylococcus aureus infection.

Authors:  Jenna Thomason; Christopher Rentsch; Edward A Stenehjem; Alicia I Hidron; David Rimland
Journal:  Infection       Date:  2015-07-04       Impact factor: 3.553

3.  Vitamin D sufficiency and Staphylococcus aureus infection in children.

Authors:  Jeffrey W Wang; Patrick G Hogan; David A Hunstad; Stephanie A Fritz
Journal:  Pediatr Infect Dis J       Date:  2015-05       Impact factor: 2.129

Review 4.  Targeting the host-pathogen interface for treatment of Staphylococcus aureus infection.

Authors:  Bonggoo Park; George Y Liu
Journal:  Semin Immunopathol       Date:  2011-11-17       Impact factor: 9.623

5.  Healthcare costs of methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa infections in veterans: role of vitamin D deficiency.

Authors:  D Youssef; B Bailey; A El-Abbassi; M Vannoy; T Manning; J P Moorman; A N Peiris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-22       Impact factor: 3.267

6.  Antimicrobial implications of vitamin D.

Authors:  Dima A Youssef; Christopher Wt Miller; Adel M El-Abbassi; Della C Cutchins; Coleman Cutchins; William B Grant; Alan N Peiris
Journal:  Dermatoendocrinol       Date:  2011-10-01

7.  Could vitamin d have a potential anti-inflammatory and anti-infective role in bronchiectasis?

Authors:  Jim Bartley; Jeff Garrett; Cameron C Grant; Carlos A Camargo
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 8.  Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

Authors:  Mark Boguniewicz; Donald Y M Leung
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

9.  Risk Factors Associated with Vitamin D Status among Older Puerto Rican Adults.

Authors:  Oladimeji J Akinlawon; Chao-Qiang Lai; Sabrina E Noel; Kaylea D Flanagan; Katherine L Tucker
Journal:  J Nutr       Date:  2021-04-08       Impact factor: 4.798

10.  Vitamin D and sepsis: An emerging relationship.

Authors:  Jordan A Kempker; Jenny E Han; Vin Tangpricha; Thomas R Ziegler; Greg S Martin
Journal:  Dermatoendocrinol       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.